Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
作者:
主题词
人类(Humans);质子泵抑制剂(Proton Pump Inhibitors);队列研究(Cohort Studies);组胺(Histamine);倾向性评分(Propensity Score);糖尿病(Diabetes Mellitus);组胺H2拮抗剂(Histamine H2 Antagonists);高血压(Hypertension);血脂异常(Dyslipidemias)
DOI
10.3346/jkms.2023.38.e99
PMID
37012686
发布时间
2023-04-06
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文